SCHEMBL1089544

SCHEMBL1089544

CN1CCCC1CCNc1nc(N2CC3CCC(CC3)C2)c2ccccc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.56
HRH1 P35367 1/20 0.56
HRH3 Q9Y5N1 1/20 0.56
ACP1 P24666 2/20 0.52
MRGPRX1 Q96LB2 1/20 0.47
CAMK2D Q13557 1/20 0.45
RAD52 P43351 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
SLC2A1 P11166 1/20 0.42
ACKR3 P25106 1/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
NMT1 P30419 1/20 0.41
AURKA O14965 1/20 0.41
LCK P06239 1/20 0.41
KDR P35968 1/20 0.41
TEK Q02763 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090557 0.93 HRH2 (0.57) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1089426 0.92 HRH2 (0.58) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1090440 0.92 HRH2 (0.58) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1088519 0.92 HRH2 (0.58) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1089099 0.89 KAT2B (0.49) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1090562 0.86 HRH2 (0.53) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1090499 0.81 MRGPRX1 (0.53) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1089195 0.81 MRGPRX1 (0.55) HRH3ACP1MRGPRX1RAD52SLC2A1
SCHEMBL1089408 0.81 MRGPRX1 (0.52) HRH2HRH1HRH3ACP1MRGPRX1
SCHEMBL1089089 0.80 MRGPRX1 (0.54) HRH3ACP1MRGPRX1RAD52SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HRH2 261/4885HRH1 155/4885HRH3 94/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 HRH2 261/4885HRH1 155/4885HRH3 94/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HRH2 261/4885HRH1 155/4885HRH3 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.